Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Urology
  •  General Surgery
  •  Obstetrics Surgery
  •  Vascular Surgery
  •  Emergency Surgery
  •  Gastroenterological Surgery
  •  Pediatric Surgery
  •  Minimally Invasive Surgery

Abstract

Citation: Clin Surg. 2020;5(1):2851.Review Article | Open Access

CRISPR-Mediated Genome Editing in the Field of Surgery: Review

Hiroshi Kanno1,2*, Tetsuya Yoshizumi1, Kimihiro Nakahara1, Masamichi Shinonaga1 and Hoi-Sang U2

1Department of Neurosurgery, International University of Health and Welfare Atami Hospital, Atami, Japan
2Division of Neurosurgery, Veterans Administration San Diego Healthcare System, University of California San Diego, USA

*Correspondance to: Hiroshi Kanno 

 PDF  Full Text DOI: 10.25107/2474-1647.2851

Abstract

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) associated protein 9 (Cas9) genome editing technology represents an exciting area of surgery. CRISPR/Cas9-mediated genome editing technology has been extensively applied in various cells and organisms, both in vitro and in vivo, for efficient gene disruption and gene modification. The CRISPR/Cas9 system was described initially in 2012 for gene editing in bacteria and then in human cells, and since then, a number of modifications have improved the efficiency and specificity of gene editing. CRISPR/Cas9 genome editing technology has shown great promise for the cancer treatment, organ transplantation/regeneration, cardiovascular surgery, and neurological surgery. In this review we describe the history, mechanism, limitations and ethical concerns of CRISPR/Cas9-mediated genome editing technology, and focus on the potential applications to surgical field such cancer treatment, organ transplantation/regeneration, cardiovascular surgery, and neurological surgery. Clinical studies for surgical filed have been limited because further research is required to verify its safety in patients. Some clinical trials in cancer have opened, and early studies have shown that gene editing may have a particular role in the field of organ transplantation and neu

Keywords

Cite the article

Kanno H, Yoshizumi T, Nakahara K, Shinonaga M, Hoi-Sang U. CRISPRMediated Genome Editing in the Field of Surgery: Review. Clin Surg. 2020; 5: 2851..

Search Our Journal

Journal Indexed In

Articles in PubMed

Risk Factors for Visual Impairment in an Uninsured Population and the Impact of the Affordable Care Act
 PubMed  PMC  PDF  Full Text
Sildenafil Transiently Delays Early Alveolar Bone Healing of Tooth Extraction Sockets
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Systematical Analysis of Circular RNAs in Triple Negative Breast Cancer
 Abstract  PDF  Full Text
A Comparison of a Laparoscopic Kidney Transplantation Technique and an Open Approach in a Pig Model
 Abstract  PDF  Full Text
View More...